Cargando…
Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis
Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and hepatocyte injury and constitutes hepatic manifestation of the metabolic syndrome. The pathogenesis of NASH is complex and implicates cross-talk between different metabolically active sites, such as...
Autores principales: | Vonghia, Luisa, Michielsen, Peter, Francque, Sven |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3821591/ https://www.ncbi.nlm.nih.gov/pubmed/24084730 http://dx.doi.org/10.3390/ijms141019867 |
Ejemplares similares
-
Pharmacological Treatment for Non-alcoholic Fatty Liver Disease
por: Francque, Sven, et al.
Publicado: (2019) -
Epidemiology and treatment of autoimmune hepatitis
por: Francque, Sven, et al.
Publicado: (2012) -
Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
por: Vonghia, Luisa, et al.
Publicado: (2015) -
Non-Alcoholic Steatohepatitis Decreases Microsomal Liver Function in the Absence of Fibrosis
por: Verlinden, Wim, et al.
Publicado: (2020) -
Targeting Myeloid-Derived Cells: New Frontiers in the Treatment of Non-alcoholic and Alcoholic Liver Disease
por: Vonghia, Luisa, et al.
Publicado: (2019)